Sanuo Biotech: The company's current domestic blood glucose monitoring system test strips can achieve an annual production capacity of 4.3 billion.

On July 17th, Sanuo Bio announced on an interactive platform that the company's current domestic blood glucose monitoring system test strips have a production capacity of 4.3 billion per year, and the design capacity of the continuous glucose monitoring system's fully automated production line is 20 million sets per year. The company will arrange the production capacity reasonably based on market demand and business development.